The BRAIN Foundation at Paxmedica’s NASDAQ Closing Bell Event
It was a great honor for The BRAIN Foundation to join the PaxMedica team as they rang the NASDAQ Closing Bell last week.
PaxMedica is is a clinical-stage biopharmaceutical company spearheading the development of innovative treatments for unmet needs in neurodevelopmental disorders, including Autism Spectrum Disorder and Fragile X-associated tremor/ataxia (FXTAS).
Our thanks to Howard Weisman, CEO of PaxMedica, for his kind words recognizing the partnership with BRAIN over the last couple of years.
Watch highlights of the event:
RESOURCES & PUBLICATIONS